[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Benef](https://github.com/mm80843/T3.5/tree/main/docs/Benef/index.md) >> Individual ID:PBN__Benef_402 

# __Reduced healthcare demand__

## Articles mentionning this Benefit

* [Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_80.md)

## Category to which it belongs

* [Enhanced healthcare accessibility, quality, outcomes, and efficiency, along with reduced burden and inequalities, leading to improved public health.](https://github.com/mm80843/T3.5/blob/pages/PBNCategory/PBN__PBNCategory_14.md)

## Description of actual returns pertaining to this benefit

* [Private investors could benefit by investing in measures that reduce healthcare demand as it would alleviate strain on healthcare facilities, potentially leading to improved efficiency and better quality of care.](https://github.com/mm80843/T3.5/blob/pages/BenefReturn/PBN__BenefReturn_432.md)

## Name of the Benefit

Reduces the number of cases requiring hospitalization, lowering the demand on healthcare systems, particularly intensive care units

## Risks which can benefit from this action

* [Home isolation of suspect cases](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_406.md)

## Stakeholders benefitting from this Benefit

* [Healthcare systems](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_193.md)

